Assistant Secretary for Administration for Strategic Preparedness and Response; Delegation of Authority, 58363 [2022-20737]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 185 / Monday, September 26, 2022 / Notices
Dated: September 9, 2022.
Paul Reed,
Deputy Assistant Secretary for Health,
(Disease Prevention and Health Promotion).
[FR Doc. 2022–20693 Filed 9–23–22; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Assistant Secretary for Administration
for Strategic Preparedness and
Response; Delegation of Authority
Notice is hereby given that I have
delegated to the Assistant Secretary for
Preparedness and Response (ASPR), or
their successor, the priorities authority
under Section 101 of the Defense
Production Act (DPA) of 1950, as
amended (50 U.S.C. 4501, et seq.), as
delegated to the Secretary of the U.S.
Department of Health and Human
Services (HHS) by section 201 of
Executive Order 13603, dated March 16,
2012 (77 FR 16651; 3 CFR, 2012, Comp.,
p. 225), subject to the limitation stated
herein. The delegation authorizes the
ASPR, on behalf of the Secretary, to
approve DO–HR 1 priority rating
requests for health resources that
promote the national defense. The
delegation excludes the authority to
approve all priorities provisions for
health resources that require DX–HR
priority ratings. This delegation does
not confer authority to issue regulations.
FOR FURTHER INFORMATION CONTACT:
Paige Ezernack; Defense Production Act
Office; Administration for Strategic
Preparedness and Response; U.S.
Department of Health and Human
Services; phone: (202) 260–0365; email:
Paige.Ezernack@hhs.gov.
Xavier Becerra,
Secretary.
[FR Doc. 2022–20737 Filed 9–23–22; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee
on the Validation of Alternative
Methods Biennial Progress Report:
2020–2021; Availability of Report
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Toxicology
Program (NTP) Interagency Center for
SUMMARY:
1 Or
another equivalent rating designation.
VerDate Sep<11>2014
16:43 Sep 23, 2022
Jkt 256001
the Evaluation of Alternative
Toxicological Methods (NICEATM)
announces availability of the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM) Biennial Progress Report:
2020–2021. This report, prepared in
accordance with requirements of the
ICCVAM Authorization Act of 2000,
describes activities and
accomplishments from January 2020
through December 2021.
ADDRESSES: The report is available at
https://ntp.niehs.nih.gov/go/
2021iccvamreport.
FOR FURTHER INFORMATION CONTACT: Dr.
Nicole Kleinstreuer, Acting Director,
NICEATM, Division of Translational
Toxicology, NIEHS, P.O. Box 12233,
K2–17, Research Triangle Park, NC
27709. Phone: 984–287–3150, Email:
nicole.kleinstreuer@nih.gov. Hand
Deliver/Courier address: 530 Davis
Drive, Room K2032, Morrisville, NC
27560.
SUPPLEMENTARY INFORMATION:
Background
The ICCVAM Authorization Act of
2000 established ICCVAM as a
permanent interagency committee of the
National Institute of Environmental
Health Sciences (NIEHS) under
NICEATM. ICCVAM’s mission is to
facilitate development, validation, and
regulatory acceptance of new and
revised regulatory test methods that
reduce, refine, or replace the use of
animals in testing while maintaining
and promoting scientific quality and the
protection of human health, animal
health, and the environment.
A provision of the ICCVAM
Authorization Act states that ICCVAM
shall prepare ‘‘reports to be made
available to the public on its progress
under this Act.’’ The eleventh progress
report describing ICCVAM activities and
accomplishments from January 2020
through December 2021 is now
available.
Summary of Report Contents: Key
ICCVAM, ICCVAM agency, and
NICEATM accomplishments
summarized in the report include:
• Publication by the Organisation for
Economic Co-operation and
Development of Guideline 497, Defined
Approaches on Skin Sensitisation, the
first internationally harmonized
guideline to describe a non-animal
approach that can be used to replace an
animal test to identify skin sensitizers.
Guideline 497 was drafted and
sponsored by ICCVAM agency scientists
and international partners.
• Recommendations in March 2021
by the ICCVAM Metrics Workgroup on
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
58363
federal agency progress in promoting
alternative toxicological methods. The
workgroup recommended each agency
develop its own metrics relevant and
practical to their own situation.
• Establishment of the Workgroup on
Microphysiological Systems for COVID
Research, an international collaborative
workgroup to coordinate use of
microphysiological systems to reduce
animal use in COVID–19 studies and
future emerging infectious diseases. A
key accomplishment of the workgroup
was the establishment of a COVID–19
disease portal in an existing
microphysiological systems database.
• Further development of the
Collaborative Acute Toxicity Modeling
Suite (CATMoS), an online resource for
in silico screening of organic chemicals
for acute oral toxicity. During 2020 and
2021, the utility of CATMoS for
predicting acute oral toxicity in research
and regulatory contexts was explored in
projects conducted by ICCVAM
agencies, including the U.S. Department
of Defense and the U.S. Environmental
Protection Agency.
• Updates of the Integrated Chemical
Environment Search tool during 2020
and 2021 to enable search results to be
sent to query other data resources.
Updates also allowed users to explore
similarities among chemicals, find
information on chemical use categories,
search for structurally similar
chemicals, and view and interact with
concentration-response curves from
curated high-throughput screening data.
Availability of Report: The report is
available at https://ntp.niehs.nih.gov/
go/2021iccvamreport. Links to this
report and all past ICCVAM annual and
biennial reports are available at https://
ntp.niehs.nih.gov/go/iccvam-bien.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 17 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability. ICCVAM also
promotes the scientific validation and
regulatory acceptance of testing
methods that more accurately assess the
safety and hazards of chemicals and
products and replace, reduce, or refine
animal use.
The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) establishes
ICCVAM as a permanent interagency
committee of NIEHS and provides the
authority for ICCVAM involvement in
activities relevant to the development of
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 87, Number 185 (Monday, September 26, 2022)]
[Notices]
[Page 58363]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20737]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Assistant Secretary for Administration for Strategic Preparedness
and Response; Delegation of Authority
Notice is hereby given that I have delegated to the Assistant
Secretary for Preparedness and Response (ASPR), or their successor, the
priorities authority under Section 101 of the Defense Production Act
(DPA) of 1950, as amended (50 U.S.C. 4501, et seq.), as delegated to
the Secretary of the U.S. Department of Health and Human Services (HHS)
by section 201 of Executive Order 13603, dated March 16, 2012 (77 FR
16651; 3 CFR, 2012, Comp., p. 225), subject to the limitation stated
herein. The delegation authorizes the ASPR, on behalf of the Secretary,
to approve DO-HR \1\ priority rating requests for health resources that
promote the national defense. The delegation excludes the authority to
approve all priorities provisions for health resources that require DX-
HR priority ratings. This delegation does not confer authority to issue
regulations.
---------------------------------------------------------------------------
\1\ Or another equivalent rating designation.
FOR FURTHER INFORMATION CONTACT: Paige Ezernack; Defense Production Act
Office; Administration for Strategic Preparedness and Response; U.S.
Department of Health and Human Services; phone: (202) 260-0365; email:
_____________________________________-
[email protected].
Xavier Becerra,
Secretary.
[FR Doc. 2022-20737 Filed 9-23-22; 8:45 am]
BILLING CODE 4150-37-P
